## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-05-19T22:37:59.220Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "ASCCP Management Guidelines"
developer_entity: "American Society for Colposcopy and Cervical Pathology Inc"
bundle_id: "org.asccp.app2019"
app_store_id: "1498550832"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: true
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-03-04"
report_date: "2026-05-19"
last_verified: "2026-05-19"
report_version: "2.4.1"
total_reviews: 8661
overall_rating: 4.76
sentiment: "Upset"
sentiment_score: 25
confidence: "high"
confidence_score: 0.9
top_praise_theme: "Clinical utility of the diagnostic tool remains high for daily patient management tasks"
top_complaint_theme: "Navigation regressions post-update force users into confusing, non-linear clinical decision pathways"
top_request_theme: "Restoration of the original flow chart visualization for clinical decision support"
review_sample_size: 103
total_review_count: 103
analyzed_review_count: 70
data_age_days: 0
momentum_velocity: "maintenance"
intelligence_version: 4
nemesis: "DynaMed"
competitor_count: 7
tags: ["medical", "paid", "upset sentiment", "mobile app", "app review", "app analysis", "healthcare", "professionals,", "including"]
canonical_url: "https://marlvel.ai/intel-report/medical/asccp-management-guidelines"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# ASCCP Management Guidelines App Audit

## TL;DR {#tldr}

- **Category**: Medical · Paid
- **Signal**: Rating 4.76 · Sentiment Upset
- **Recent focus**: Navigation regressions post-update force users into confusing, non-linear clinical decision pathways (top complaint) · Clinical utility of the diagnostic tool remains high for daily patient management tasks (top praise) · Restoration of the original flow chart visualization for clinical decision support (top request)

> **TL;DR:** ASCCP Management Guidelines is a medical app by American Society for Colposcopy and Cervical Pathology Inc, rated 4.76/5 by 8.7K users, with Upset user sentiment (25/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** ASCCP Management Guidelines faces Upset user sentiment (4.76/5 from 8.7K reviews), with navigation regressions post-update force users into confusing, non-linear clinical decision pathways as the primary user concern.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 4.76/5 (8.7K reviews) |
| **User Mood** | Upset |
| **Category** | Medical |
| **Developer** | American Society for Colposcopy and Cervical Pathology Inc |
| **Pricing** | Paid |
| **Platforms** | iOS & Android |
| **Confidence** | High (0.9/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** American Society for Colposcopy and Cervical Pathology Inc
- **Category:** Medical
- **Target Audience:** Healthcare professionals, including clinicians and residents, involved in the diagnosis and management of anogenital and HPV-related diseases.
- **Platforms:** iOS & Android
- **Version Audited:** 2.4.1
- **Audit Date:** 2026-05-19
- **Signal Count:** 103 reviews analyzed
- **Confidence:** High (0.9/1.0)
- **App Store ID (iOS):** 1498550832
- **Bundle ID:** org.asccp.app2019
- **Google Play ID:** org.asccp.app2019
- **Performance Trend:** Declining
- **Data Window:** Analysis based on signals collected up to 2026-05-19
- **Short Description:** ASCCP Management Guidelines- There’s an app for that!

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** ASCCP Management Guidelines is a clinical decision support tool for healthcare professionals, providing evidence-based management recommendations for cervical cancer screening on iOS and Android.
**Why users hire it:** Clinicians hire this tool to navigate complex, consensus-based cervical cancer screening protocols, ensuring patient care aligns with the latest medical standards without manual research.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Risk-Based Management Algorithms:** Calculates clinical next-step recommendations for abnormal cervical cancer screening results based on consensus guidelines
  * *User Intent:* Users need clear guidance to understand and adopt the product quickly.
- **[Standard] Offline Flowchart Access:** Allows users to bookmark and view clinical decision flowcharts without an active internet connection
  * *User Intent:* Users want uninterrupted access without internet dependency.
- **[Differentiator] Push Alerts:** Sends notifications to users when clinical guidelines are updated by ASCCP experts
  * *User Intent:* Users want timely prompts to stay engaged without missing updates.
- **[Differentiator] Member-Only Resource Access:** Provides access to clinical documents, EMR templates, and case studies via member login
  * *User Intent:* Users are motivated by consistent progression and daily incentives.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

The app holds a #14 Top Paid position in the US Medical category, but the recent sentiment decline suggests this rank is legacy-driven rather than performance-based. The gap between the $14.99 price point and the current technical instability creates a high churn risk against free alternatives like MDCalc.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** One-time purchase of $14.99 for the app, Membership required for additional clinical resources
- **Price:** iOS: $14.99 | Android: $14.99
- **Analysis:** Paid model anchored at $14.99, supplemented by membership-gated content to drive professional association revenue.

<!-- section:sentiment -->
## 🔴 User Sentiment (High Confidence: 70 of 103 reviews analyzed) {#user-sentiment}
- **Overall Rating:** 4.76/5
- **Platform Split:** iOS 4.8/5 (8.4K ratings) | Android 4.5/5 (304 ratings)
- **Overall Sentiment:** Upset
- **Note:** The 4.76/5 store rating reflects cumulative history, while the Upset sentiment reflects recent user reviews analyzed by our AI pipeline.

### Top Praises
- **Clinical utility of the diagnostic tool remains high for daily patient management tasks**

### Top Complaints (Impact Areas)
- **Navigation regressions post-update force users into confusing, non-linear clinical decision pathways**
- **Technical instability and UI glitches prevent accurate data entry on mobile devices**
- **Inconsistent clinical recommendations between the mobile app and web-based guidelines**

### Top Requests (What Users Want)
- **Restoration of the original flow chart visualization for clinical decision support**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Official consensus status functions as a B2B distribution moat into clinical practice
- Offline access ensures utility in connectivity-constrained hospital environments

**Critical Frictions:**
- Navigation regressions in the latest update create logic loops
- Inconsistent clinical recommendations between mobile and web versions erode professional trust

**Growth Levers:**
- Integration of EMR templates could increase stickiness
- Expansion of HPV self-collection content addresses emerging clinical needs

**Market Threats:**
- DynaMed’s institutional access model undercuts individual app sales
- UpToDate’s EMR integration captures the clinical workflow before users open the ASCCP app

<!-- /section:swot -->
## Recent Changes (v3 → v4) {#recent-changes}

The app is undergoing a critical technical and UX decline, forcing a strategic pivot to restore core visual navigation while facing increased competitive pressure from EMR-integrated alternatives.

**Overall trend**: Declining
**Compared at**: 2026-05-19

### High-impact changes
- **[Declined] Sentiment and UX Stability** (sentiment) — Overall sentiment shifted from 'mixed' to 'terrible', with specific complaints now citing non-linear logic loops and input field failures.
- **[Declined] Market Ranking Decline** (positioning) — App store ranking dropped from #5 to #14 in the US Medical category.

### Medium-impact changes
- **[Added] Feature Set Expansion** (features) — Added 'Offline Flowchart Access' and 'Member-Only Resource Access' as documented features.
- **[Added] Competitive Threats** (swot) — Added institutional access models (DynaMed) and EMR-integrated workflows (UpToDate) as primary threats to market share.

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### ASCCP Management Guidelines vs DynaMed — Head to Head
- **[DynaMed](https://marlvel.ai/intel-report/medical/dynamed)** by EBSCO Publishing: DynaMed provides a direct clinical decision support alternative that mirrors the evidence-based, guideline-focused utility of the ASCCP app.
  - **Moat strength:** Medium — durable but contestable
  - **Key differences:**
    - Integrates broad clinical evidence across specialties rather than focusing exclusively on cervical cancer screening protocols.
    - Utilizes a subscription-based institutional access model that lowers the barrier to entry for hospital-wide clinical adoption.

### Peers (What They Do Better)
- **[UpToDate](https://marlvel.ai/intel-report/medical/uptodate)** by UpToDate, Inc.: While broader in scope, it is the primary clinical reference tool clinicians use to cross-reference ASCCP guidelines.
  - Maintains a massive, multi-specialty knowledge base that serves as the default clinical reference for most practitioners.
  - Offers deep integration with electronic health records, making it a persistent fixture in the clinical workflow.
- **[MDCalc Medical Calculator](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator)** by MD Aware, LLC: Provides the functional utility of risk-based calculation, which is the core mechanism of the ASCCP management guidelines.
  - Focuses on rapid, interactive clinical calculators that provide immediate risk scores for various medical conditions.
  - Employs a high-frequency update cycle that ensures clinical formulas remain compliant with the latest medical literature.
- **[VisualDx](https://marlvel.ai/intel-report/medical/com-logicalimages-visualdxmobile)** by Logical Images: Adjacent clinical diagnostic tool that uses visual evidence to support decision-making, similar to the ASCCP's evidence-based approach.
  - Prioritizes image-based diagnostic support for dermatological and systemic conditions, complementing text-heavy guideline apps.
  - Provides a unique visual search interface that allows clinicians to compare patient symptoms against a curated image library.
- **[CDC Vaccine Schedules](https://marlvel.ai/intel-report/medical/gov-cdc-ncird-vaccinesschedule)** by Centers For Disease Control and Prevention: Represents the same 'official guideline' distribution model, serving as a trusted source for public health recommendations.
  - Distributes authoritative, government-sanctioned public health schedules that require zero-cost access for all clinicians.
  - Operates as a single-purpose utility app with a narrow focus on immunization compliance and scheduling.

### New Kids on the Block (What's Innovative)
- **[Figure 1 - Medical Cases](https://marlvel.ai/intel-report/medical/figure-1-medical-cases)** by Figure 1, Inc.: Demonstrates high engagement velocity with 9 releases in the last six months, signaling a shift toward community-based learning.
- **[Doximity](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10)** by Doximity: Maintains an aggressive release cadence of 20 updates in six months, positioning itself as the central hub for physician networking.

<!-- /section:rivals -->
<!-- section:whats-new -->
## What's New

- **Latest (v1.1, 5 years ago):** Integrated 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening and cancer precursors.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Incorporated HPV self-collection recommendations.
- Latest release focused on stability.

> **Cadence:** 5 total versions · 5 majors in last 6 months · 76 days since last update · 62 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

ASCCP Management Guidelines is a challenged medical app that is a paid app.
With a 4.76/5 rating from 8.7K reviews, it faces significant user friction.

<!-- speakable-start -->
> **Bottom Line:** The app maintains its category lead through authoritative content, but the latest update’s navigation regressions are actively driving clinicians toward more stable alternatives, so the PM must prioritize restoring the visual flowchart interface to protect the user base.
<!-- speakable-end -->

**Best for:** Healthcare professionals, including clinicians and residents, involved in the diagnosis and management of anogenital and HPV-related diseases.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] [HIGH IMPACT] Restore visual flowchart interface because users report navigation regressions in the latest update → reduce decision friction — *Top complaint theme identifies the removal of flowcharts as the primary driver of negative sentiment.* _(trade-off: deprioritize Pause the EMR template integration sprint — restoring core utility is a prerequisite for retention.)_
- [ ] [MAINTAIN] [HIGH IMPACT] Audit logic engine to align mobile and web recommendations because clinicians report guideline discrepancies → restore professional trust — *Inconsistent clinical advice is a critical risk to the app's authority as a medical reference.* _(trade-off: deprioritize Same-quarter capacity available — no major lever displaced.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- Deep EMR integration (available in UpToDate but absent here)
- Interactive, rapid-fire clinical calculators (available in MDCalc but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Declining

The clinical reference market is consolidating around tools that offer seamless EMR integration and high-frequency updates, leaving ASCCP exposed due to its recent technical instability. Unless the team restores the intuitive flowchart interface and resolves cross-platform guideline discrepancies, the app will likely see a continued decline in active usage as clinicians migrate to more reliable, multi-specialty alternatives.

- 🔴 Navigation regressions in the latest update force users into non-linear logic loops, which increases churn risk among daily clinical users.
- 🔴 Discrepancies between mobile and web-based guidelines undermine the app's authority, potentially leading to a permanent loss of professional trust.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 4.76/5 |
| Total Reviews | 8.7K |
| Sentiment | Upset (25/100) |
| Confidence | High |
| Pricing Model | Paid |
| Platforms | iOS & Android |
| Key Features | 4 analyzed |
| Trend | Declining |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **ASCCP Management Guidelines** (this app) | 4.76/5 | Upset | American Society for Colposcopy and Cervical Pathology Inc |
| [Doximity](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10) | 4.8/5 | N/A | Doximity |
| [VisualDx](https://marlvel.ai/intel-report/medical/com-logicalimages-visualdxmobile) | 4.4/5 | N/A | Logical Images |
| [CDC Vaccine Schedules](https://marlvel.ai/intel-report/medical/gov-cdc-ncird-vaccinesschedule) | 3.5/5 | N/A | Centers For Disease Control and Prevention |
| [UpToDate](https://marlvel.ai/intel-report/medical/uptodate) | 4.3/5 | N/A | UpToDate, Inc. |
| [MDCalc Medical Calculator](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator) | 4.9/5 | N/A | MD Aware, LLC |

## Company Profile
- **Developer:** American Society for Colposcopy and Cervical Pathology Inc
- **Website:** [https://www.asccp.org/](https://www.asccp.org/)
- **Social:** [Instagram](https://www.instagram.com/asccp1) · [Facebook](https://www.facebook.com/ASCCP) · [X/Twitter](https://twitter.com/ASCCP) · [LinkedIn](https://www.linkedin.com/company/asccp)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/asccp-management-guidelines/id1498550832?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=org.asccp.app2019&hl=en&gl=us)
- **Dev Site:** [Official Website](https://www.asccp.org/)
- **Sources:** Developer website content, About us / company information, App store metadata, User reviews.

## Related Intel Reports
- [*Doximity*](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10) (Doximity) — 4.8/5 Rating | N/A Sentiment
- [*VisualDx*](https://marlvel.ai/intel-report/medical/com-logicalimages-visualdxmobile) (Logical Images) — 4.4/5 Rating | N/A Sentiment
- [*CDC Vaccine Schedules*](https://marlvel.ai/intel-report/medical/gov-cdc-ncird-vaccinesschedule) (Centers For Disease Control and Prevention) — 3.5/5 Rating | N/A Sentiment
- [*UpToDate*](https://marlvel.ai/intel-report/medical/uptodate) (UpToDate, Inc.) — 4.3/5 Rating | N/A Sentiment
- [*MDCalc Medical Calculator*](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator) (MD Aware, LLC) — 4.9/5 Rating | N/A Sentiment
- [*Figure 1 - Medical Cases*](https://marlvel.ai/intel-report/medical/figure-1-medical-cases) (Figure 1, Inc.) — 4.7/5 Rating | N/A Sentiment
- [*DynaMed*](https://marlvel.ai/intel-report/medical/dynamed) (EBSCO Publishing) — 4.9/5 Rating | N/A Sentiment
- [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*Ortho Traumapedia*](https://marlvel.ai/intel-report/medical/orthotraumapedia) (HTG, LLC) — 3.5/5 Rating | N/A Sentiment
- [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.9/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 103
- **Data Sources:** user reviews, developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/asccp-management-guidelines)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.